ArticleBMC endocrine disorders2026
Surgical outcomes of endoscopic endonasal surgery for nonfunctioning pituitary adenoma in elderly patients: a comprehensive analysis beyond age : Surgery for pituitary adenoma among elderly patients.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDue to the rapid aging of the global population, it is challenging to identify elderly individuals who are optimal candidates for the surgical treatment of pituitary neuroendocrine tumors. While chronological age has traditionally influenced surgical decision-making, the independent effect of age on outcomes requires a comprehensive evaluation that controls for comorbidities and tumor characteristics.
methodsThis retrospective analysis included 305 patients (≥18 years) who underwent endoscopic endonasal surgery for clinically nonfunctioning pituitary neuroendocrine tumors between March 2020 and February 2024 at a single tertiary center. Patients were stratified by age (<65 vs. ≥65 years) and evaluated using propensity score matching. The outcomes included gross total resection rates, complications, endocrinological recovery, and visual outcomes. Composite outcome measures were developed to assess multifaceted surgical success. Maximally selected rank statistics identified optimal age cutoffs for hormone recovery.
resultsThe cohort included 305 patients. Elderly patients (≥65 years, n=105) presented with significantly greater comorbidity burdens, including hypertension and diabetes. Following propensity score matching (n=105 per group), no significant age-based differences were observed in terms of gross total resection rates (84.8% vs. 84.8%) or major complications. Age 57 was found to be the optimal cutoff for endocrinological recovery (60.7% vs. 33.1%, p<0.001), with the gonadotroph axis being the most significantly affected hormone axis. The visual outcomes demonstrated remarkable age independence, as recovery was mainly dependent on gross total resection and preoperative visual field severity. Multivariate analysis demonstrated that higher body mass index (BMI), specific cardiovascular comorbidities, and intraoperative cerebrospinal fluid leaks, rather than chronological age, served as independent predictors of adverse outcomes, including surgical site infections and prolonged hospital stays.
conclusionChronological age alone should not constitute an absolute contraindication to endoscopic pituitary surgery. These findings underscore that comprehensive preoperative evaluations should prioritize functional status and modifiable risk factors, including cardiovascular comorbidities and BMI, to optimize outcomes for patients of all ages.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.